Sep 26, 2018
Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference
Sep 23, 2018
Immutep Enters into Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer
Sep 03, 2018
Progress Towards Clinical Development of IMP761 – A LAG-3 Agonist Antibody
Aug 21, 2018
Immutep Receives A$1.9 Million Research and Development Related Tax Rebate from French Government
Aug 15, 2018
Immutep to Present at the BioCentury 25th Annual NewsMakers in the Biotech Industry Conference
